Effects  	Effects  	 NNS	O
of  	of  	 IN	O
intravenous  	intravenous  	 JJ	B-NP
aminocaproic  	aminocaproic  	 JJ	I-NP
acid  	acid  	 NN	I-NP
on  	on  	 IN	O
exercise-induced  	exercise-induced  	 JJ	B-NP
pulmonary  	pulmonary  	 JJ	I-NP
haemorrhage  	haemorrhage  	 NNS	I-NP
( 	( 	 -LRB-	O
EIPH 	EIPH 	 NNP	B-NP
)  	)  	 -RRB-	O
The  	The  	 DT	O
antifibrinolytic 	antifibrinolytic 	 NN	B-NP
,  	,  	 ,	O
6-aminohexanoic  	6-aminohexanoic  	 CD	O
acid 	acid 	 NN	O
,  	,  	 ,	O
also  	also  	 RB	O
named  	named  	 VBN	O
aminocaproic  	aminocaproic  	 JJ	B-NP
acid  	acid  	 NN	I-NP
( 	( 	 -LRB-	O
ACA 	ACA 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
used  	used  	 VBN	O
empirically  	empirically  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
treatment  	treatment  	 NN	O
for  	for  	 IN	O
exercise-induced  	exercise-induced  	 JJ	B-NP
pulmonary  	pulmonary  	 JJ	I-NP
haemorrhage  	haemorrhage  	 NNS	I-NP
( 	( 	 -LRB-	O
EIPH 	EIPH 	 NNP	B-NP
)  	)  	 -RRB-	O
on  	on  	 IN	O
the  	the  	 DT	O
unsubstantiated  	unsubstantiated  	 JJ	O
basis  	basis  	 NN	O
that  	that  	 IN	O
transient  	transient  	 JJ	O
coagulation  	coagulation  	 JJ	B-NP
dysfunction  	dysfunction  	 NN	I-NP
may  	may  	 MD	O
contribute  	contribute  	 VB	O
to  	to  	 TO	O
its  	its  	 PRP$	O
development 	development 	 NN	O
.  	.  	 .	O
To  	To  	 TO	O
assess  	assess  	 VB	O
the  	the  	 DT	O
effect  	effect  	 NN	O
of  	of  	 IN	O
ACA  	ACA  	 NNP	B-NP
on  	on  	 IN	O
bronchoalveolar  	bronchoalveolar  	 FW	B-NP
lavage  	lavage  	 FW	I-NP
fluid  	fluid  	 FW	I-NP
( 	( 	 -LRB-	O
BALF 	BALF 	 NNP	B-NP
)  	)  	 -RRB-	O
erythrocyte  	erythrocyte  	 JJ	B-NP
counts  	counts  	 NNS	I-NP
in  	in  	 IN	O
horses  	horses  	 NNS	O
performing  	performing  	 VBG	B-NP
treadmill  	treadmill  	 JJ	I-NP
exercise  	exercise  	 NN	I-NP
at  	at  	 IN	O
an  	an  	 DT	O
intensity  	intensity  	 NN	O
greater  	greater  	 JJR	O
than  	than  	 IN	O
that  	that  	 WDT	O
needed  	needed  	 VBD	O
to  	to  	 TO	O
reach  	reach  	 VB	O
maximal  	maximal  	 JJ	B-NP
oxygen  	oxygen  	 NN	I-NP
consumption 	consumption 	 NN	I-NP
.  	.  	 .	O
Eight  	Eight  	 NNP	O
Thoroughbreds  	Thoroughbreds  	 NNP	O
were  	were  	 VBD	O
exercised  	exercised  	 VBN	O
to  	to  	 TO	O
fatigue  	fatigue  	 CD	O
3  	3  	 CD	O
times  	times  	 NNS	O
on  	on  	 IN	O
a  	a  	 DT	O
10 	10 	 CD	O
%  	%  	 NN	O
inclined  	inclined  	 VBN	O
treadmill  	treadmill  	 VBN	O
at  	at  	 IN	O
a  	a  	 DT	O
speed  	speed  	 NN	O
for  	for  	 IN	O
which  	which  	 WDT	O
the  	the  	 DT	O
calculated  	calculated  	 JJ	O
oxygen  	oxygen  	 NN	B-NP
requirement  	requirement  	 NN	I-NP
was  	was  	 VBD	O
1.15  	1.15  	 CD	O
times  	times  	 NNS	O
VO2max 	VO2max 	 VBP	O
.  	.  	 .	O
Horses  	Horses  	 NNS	O
were  	were  	 VBD	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
saline  	saline  	 JJ	B-NP
placebo 	placebo 	 NN	I-NP
,  	,  	 ,	O
2  	2  	 CD	O
and  	and  	 CC	O
7  	7  	 CD	O
g  	g  	 JJ	B-NP
ACA  	ACA  	 NNP	I-NP
i.v.  	i.v.  	 CD	I-NP
4  	4  	 CD	O
h  	h  	 NN	O
before  	before  	 IN	O
exercise 	exercise 	 NN	O
,  	,  	 ,	O
with  	with  	 IN	O
a  	a  	 DT	O
crossover  	crossover  	 JJ	O
design  	design  	 NN	O
being  	being  	 VBG	O
used  	used  	 VBN	O
to  	to  	 TO	O
determine  	determine  	 VB	O
the  	the  	 DT	O
order  	order  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
injections 	injections 	 NNS	O
.  	.  	 .	O
Exercise-induced  	Exercise-induced  	 JJ	O
pulmonary  	pulmonary  	 JJ	B-NP
haemorrhage  	haemorrhage  	 JJ	I-NP
severity  	severity  	 NN	I-NP
was  	was  	 VBD	O
quantified  	quantified  	 VBN	O
via  	via  	 IN	O
the  	the  	 DT	O
erythrocyte  	erythrocyte  	 JJ	B-NP
count  	count  	 NN	I-NP
in  	in  	 IN	O
BALF 	BALF 	 NNP	B-NP
.  	.  	 .	O
Bronchoalveolar  	Bronchoalveolar  	 JJ	B-NP
lavage  	lavage  	 JJ	I-NP
fluid  	fluid  	 NN	I-NP
was  	was  	 VBD	O
collected  	collected  	 VBN	O
4  	4  	 CD	O
h  	h  	 NN	O
before  	before  	 IN	O
and  	and  	 CC	O
30-60  	30-60  	 CD	O
min  	min  	 JJ	B-NP
post  	post  	 NN	I-NP
exercise 	exercise 	 NN	I-NP
.  	.  	 .	O
Results  	Results  	 NNS	O
were  	were  	 VBD	O
expressed  	expressed  	 VBN	O
as  	as  	 RB	O
mean  	mean  	 VB	O
±  	±  	 NNP	O
s.e.m.  	s.e.m.  	 NNP	B-NP
and  	and  	 CC	O
analysed  	analysed  	 NN	O
by  	by  	 IN	O
one  	one  	 CD	O
way  	way  	 NN	B-NP
repeated  	repeated  	 NN	I-NP
measures  	measures  	 VBZ	O
ANOVA  	ANOVA  	 NNP	B-NP
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.05 	0.05 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Aminocaproic  	Aminocaproic  	 JJ	B-NP
acid  	acid  	 NN	I-NP
administration  	administration  	 NN	I-NP
had  	had  	 VBD	O
no  	no  	 DT	O
effect  	effect  	 NN	O
on  	on  	 IN	O
any  	any  	 DT	O
measured  	measured  	 JJ	O
variables  	variables  	 NNS	O
( 	( 	 -LRB-	O
VO2max  	VO2max  	 CD	O
=  	=  	 SYM	O
48  	48  	 CD	O
±  	±  	 CD	O
3.0  	3.0  	 CD	O
[ 	[ 	 -LRB-	O
C 	C 	 NNP	O
] 	] 	 -RRB-	O
;  	;  	 :	O
148  	148  	 CD	O
±  	±  	 CD	O
3.0  	3.0  	 CD	O
[ 	[ 	 -LRB-	O
2  	2  	 CD	O
g  	g  	 JJ	B-NP
ACA 	ACA 	 NNP	I-NP
] 	] 	 -RRB-	O
;  	;  	 :	O
145  	145  	 CD	O
±  	±  	 CD	O
3.0  	3.0  	 CD	O
[ 	[ 	 -LRB-	O
7  	7  	 CD	O
g  	g  	 JJ	B-NP
ACA 	ACA 	 NNP	I-NP
]  	]  	 -RRB-	O
ml 	ml 	 FW	B-NP
/ 	/ 	 FW	I-NP
kg  	kg  	 FW	I-NP
bwt 	bwt 	 FW	I-NP
/ 	/ 	 FW	I-NP
min 	min 	 FW	I-NP
,  	,  	 ,	O
respectively 	respectively 	 RB	O
;  	;  	 :	O
run  	run  	 VB	O
time  	time  	 NN	O
=  	=  	 SYM	O
77  	77  	 CD	O
±  	±  	 CD	O
3  	3  	 CD	O
[ 	[ 	 -LRB-	O
C 	C 	 NNP	O
] 	] 	 -RRB-	O
;  	;  	 :	O
75  	75  	 CD	O
±  	±  	 CD	O
2  	2  	 CD	O
[ 	[ 	 -LRB-	O
2  	2  	 CD	O
g  	g  	 JJ	B-NP
ACA 	ACA 	 NNP	I-NP
] 	] 	 -RRB-	O
;  	;  	 :	O
79  	79  	 CD	O
±  	±  	 CD	O
3  	3  	 CD	O
[ 	[ 	 -LRB-	O
7  	7  	 CD	O
g  	g  	 JJ	B-NP
ACA 	ACA 	 NNP	I-NP
]  	]  	 -RRB-	O
seconds 	seconds 	 NNS	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
) 	) 	 -RRB-	O
.  	.  	 .	O
All  	All  	 DT	O
horses  	horses  	 NNS	O
developed  	developed  	 VBD	B-NP
EIPH 	EIPH 	 NNP	I-NP
:  	:  	 :	O
1691  	1691  	 CD	O
±  	±  	 CD	O
690  	690  	 CD	O
vs.  	vs.  	 IN	O
9637  	9637  	 CD	O
±  	±  	 CD	O
3923  	3923  	 CD	O
( 	( 	 -LRB-	O
C 	C 	 NNP	O
) 	) 	 -RRB-	O
;  	;  	 :	O
2149  	2149  	 CD	O
±  	±  	 CD	O
935  	935  	 CD	O
vs.  	vs.  	 IN	O
3378  	3378  	 CD	O
±  	±  	 CD	O
893  	893  	 CD	O
( 	( 	 -LRB-	O
2  	2  	 CD	O
g  	g  	 JJ	B-NP
ACA 	ACA 	 NNP	I-NP
) 	) 	 -RRB-	O
;  	;  	 :	O
1058  	1058  	 CD	O
±  	±  	 CD	O
340  	340  	 CD	O
vs.  	vs.  	 IN	O
4533  	4533  	 CD	O
±  	±  	 CD	O
791  	791  	 CD	O
( 	( 	 -LRB-	O
7  	7  	 CD	O
g  	g  	 JJ	B-NP
ACA 	ACA 	 NNP	I-NP
)  	)  	 -RRB-	O
erythrocytes 	erythrocytes 	 FW	B-NP
/ 	/ 	 FW	I-NP
µl  	µl  	 FW	I-NP
pre-  	pre-  	 FW	I-NP
vs.  	vs.  	 FW	I-NP
post  	post  	 NN	O
exercise  	exercise  	 NN	O
recovered  	recovered  	 VBD	O
in  	in  	 IN	O
BALF 	BALF 	 NNP	B-NP
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
Aminocaproic  	Aminocaproic  	 JJ	B-NP
acid  	acid  	 NN	I-NP
was  	was  	 VBD	O
not  	not  	 RB	O
effective  	effective  	 JJ	O
in  	in  	 IN	O
preventing  	preventing  	 VBG	O
or  	or  	 CC	O
reducing  	reducing  	 VBG	O
the  	the  	 DT	O
severity  	severity  	 NN	O
of  	of  	 IN	O
EIPH  	EIPH  	 NNP	B-NP
or  	or  	 CC	O
improving  	improving  	 VBG	B-NP
performance  	performance  	 NN	I-NP
under  	under  	 IN	O
the  	the  	 DT	O
exercise  	exercise  	 NN	B-NP
conditions  	conditions  	 NNS	I-NP
of  	of  	 IN	O
this  	this  	 DT	O
study 	study 	 NN	O
.  	.  	 .	O
